Effect of Lavender Oil Inhalation in Colonoscopy Patients
Colonic Disease
About this trial
This is an interventional supportive care trial for Colonic Disease focused on measuring colonoscopy, aromatherapy, anxiety, comfort, lavander oil
Eligibility Criteria
Inclusion Criteria:
- over 18 years old, 65 years old and under,
- having colonoscopy,
- not having the risk of heart failure and cardiogenic shock (class III and IV),
- not having a history of asthma, eczema, and allergies to flowers and plants,
- not allergic to lavender,
- not having communicative/severe hearing or speech impairment,
- not using antidepressant, antihistamine, diuretic, hypnotic, benzodiazepine and narcotic derivatives
- having stable vital signs
- individuals who volunteered to participate in research
Exclusion Criteria:
- individuals who do not meet the inclusion criteria
Sites / Locations
- Kırklareli University
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Experimental group
Control Group
Pre-procedural information form, state-trait anxiety scale, and comfort scale were applied to patients who had planned colonoscopy. Two drops of lavender (2%) essential oil was dripped onto a 2 x 2 cm cotton gauze cloth attached to the front of the clothes of the experimental group patients, approximately 12 inches below their noses. They were asked to inhale 2% lavender essential oil for 20 minutes. They were directed to breathe normally after inhalation. Vital signs of the patients were checked before and after the procedure. After the process, the forms were filled again, the final test process was completed.
Pre-procedural information form, state-trait anxiety scale, and comfort scale were applied to patients who had planned colonoscopy. Lavender aromatherapy was not applied to the patients in this group, but routine care was applied. After the process, the forms were filled again, the final test process was completed. The data took about 15-20 minutes with face-to-face interview method.